Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference16 articles.
1. Peeters LEJ, Kester MP, Feyz L, Van Den Bemt PMLA, Koch BCP, Van Gelder T, Versmissen J. Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension. Expert Opin Drug Metab Toxicol. 2019;15(4):287–97. https://doi.org/10.1080/17425255.2019.1588249.
2. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339.
3. Lee J-H, Kim K-I, Cho M-C. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med. 2019;34(4):687–95. https://doi.org/10.3904/kjim.2019.196.
4. Nederlands Huisartsen Genootschap (NHG), 2019. Cardiovascular Risk Management (M84) [In Dutch]. NHG-guidelines. [online] Nederlands Huisartsen Genootschap (NHG). richtlijnen.nhg.org/files/pdf/93_Cardiovasculair%20risicomanagement_juni-2019.pdf. Accessed 19 May 2021.
5. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–82. https://doi.org/10.1001/jama.2016.7050.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献